Masimo (NSDQ:MASI) recently touted results from a study of its SpHb monitoring tech exploring its ability to detect possible anemia in patients undergoing spine or cytoreductive surgery, and said it won FDA 510(k) clearance for its Radius PPG tetherless sensor. The Irvine, Calif.-based company said that results from its SpHb tech were published in the journal […]
Report: Healthcare CEO pay balloons to $2.6B, quality of care not a factor in bonuses
Healthcare chief execs at 177 top companies collectively saw their compensation grow to $2.6 billion last year while quality of care and improvements to healthcare spending remained at most a marginal factor to their pay, according to an Axios analysis. Despite a focus on pharmaceutical CEOs, medical device company chief execs were five of the […]
Masimo shares dip despite Q1 earnings beat
Shares in Masimo (NSDQ:MASI) have fallen today despite the medical diagnostic maker posting first quarter 2019 earnings that topped expectations on Wall Street. The Irvine, Calif.-based company posted profits of $49.3 million, or 87¢ per share, on sales of approximately $231.7 million for the three months ended March 30, seeing 8.1% growth on the bottom line […]
Masimo touts O3 cerebral oxygenation study results
Masimo (NSDQ:MASI) today released results from a study seeking to establish a normal range of values for cerebral oxygenation and explore the relationship between cerebral oxygenation and other physical and hemodynamic characteristics using Masimo’s O3 Regional Oximetry. Results from the study were published in the journal Anaesthesia and Intensive Care, the Irvine, Calif.-based company said. Masimo […]
Masimo wins FDA 510(k) for Rad-67 pulse co-oximeter
Masimo (NSDQ:MASI) said today it won FDA 510(k) clearance for its Rad-67 pulse co-oximeter system. The Rad-67 offers both Rainbow non-invasive hemoglobin measurement and measure-through motion and low perfusion SET pulse oximetry, and can be used with the Irvine, Calif.-based company’s Rainbow DCI-mini sensor for spot-check monitoring. The system also features a rechargeable battery with a […]
Masimo wins CE Mark for next-gen SedLine pediatric brain monitor
Masimo (NSDQ:MASI) said today that it won CE Mark approval in the European Union for its next-gen SedLine brain function monitor intended for pediatric patients. The Irvine, Calif.-based company said that with the clearance, its next-gen SedLine monitoring tech is now available for all patients one year and older in CE Mark countries. Masimo said that […]
Masimo beats The Street on Q4 earnings
Masimo (NSDQ:MASI) stock is up about 5% in value today after the Irvine, Calif.– based maker of noninvasive patient monitoring technologies and sensors reported fourth-quarter results that beat analyst expectations. Masimo reported yesterday evening that it earned $46.9 million, or 83 cents per share, off $223.1 million in revenue for the quarter ended Dec. 29. Masimo lost […]
Masimo receives FDA clearance for fingertip pulse oximeter measurement
Masimo recently announced that it has received FDA clearance for its respiration rate measurement from the pleth RRp on its MightySat Rx spot-check fingertip pulse oximeter. It was also indicated for use in the home. Using the company’s RRp in MightSat Rx, respiration rate can be measured using the same optical sensor that measures SpO2, PR, […]
Globus Medical gains on Street-beating prelims | Wall Street Beat
Globus Medical (NYSE:GMED) shares closed up yesterday after the orthopedics company reported preliminary fourth-quarter and 2018 sales numbers that beat the consensus forecast on Wall Street. Audubon, Pa.-based Globus said it expects to post Q4 revenues of $195.5 million and full-year sales of $712.5 million; analysts on The Street were looking for quarterly sales of $188.2 million and […]
Masimo inks $150m credit facility deal
Masimo (NSDQ:MASI) has inked a $150 million credit facility with JP Morgan Chase and Bank of the West, according to a recently published SEC filing. The Irvine, Calif.-based company’s new facility comes with an option to increase the aggregate borrowing capacity up to $550 million, and also provides for a sublimit of up to $25 million […]
FDA chooses 8 medtech companies for opioid crisis challenge
The FDA has selected eight medtech companies to develop devices to help reduce the country’s opioid abuse crisis. More than 250 companies submitted entries to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder, announced in May. Those selected include Masimo Corp. and deep-brain-stimulation company Brainsway Ltd. The companies will be expected to […]
- 1
- 2
- 3
- …
- 19
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube